Staphylococcal Infections: Clinical Trials

2 trials for Staphylococcal Infections, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 recruiting. 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 22Recruiting 2

Follow Staphylococcal Infections: new trials by email Literature Review of Staphylococcal Infections trials Research Report on Staphylococcal Infections

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Combination Cefazolin With Ertapenem for Methicillin-susceptible Staphylococcus Aureus Bacteremia
Ertapenem, Placebo - Staphylococcus Aureus Bacteremia, Staphylococcus Aureus Septicemia
Phase 2RecruitingTodd C. Lee MD MPH FIDSA602024-05-202026-09-11
Target Attainment of Continuous Infusion Flucloxacillin and Cefazolin Coupled With TDM vs. Standard of Care Treatment in Patients With Complicated S. Aureus Infection
FLU or CZO as continuous infusion, standard FLU or CZO intermittent bolus administration - Complicated Staphylococcus Aureus (S. Aureus) Infections (CSAI)
Phase 2RecruitingUniversity Hospital, Basel, Switzerland362023-10-262024-12-16

Narrower conditions

Bacteremia (1)  ·  Infections (1)

Broader conditions

Bacterial Infections (2)  ·  Bacterial Infections and Mycoses (2)  ·  Gram-Positive Bacterial Infections (2)  ·  Infections (1)  ·  Inflammation (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Sepsis (1)  ·  Systemic Inflammatory Response Syndrome (1)

Interventions

Ertapenem (1)

Sponsors

Todd C. Lee MD MPH FIDSA (1)  ·  University Hospital, Basel, Switzerland (1)

Countries

Canada (1)  ·  Switzerland (1)

Top investigators

Emily G McDonald, MD MSc (1)  ·  Matthew P Cheng, MD (1)  ·  Michael Osthoff, PD Dr. med. (1)  ·  Todd C Lee, MD MPH FIDSA (1)

Results publications

PMID 41433510